Despite major changes coming to the EU regulatory system in under two years, many companies are still scrambling to develop strategies for handling the MDR and IVDR implementation in the region.
Last month at DeviceTalks West, Abbott regulatory affairs director Caroline Leab Byrd, R&Q regulatory affairs director Nancy Morrison and 30-year regulatory vet Artha Nafie ran through some basic steps that companies should take in preparation for the shift in the regulatory landscape.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.